Evergreen guides on purity, CoA reading, storage, and per-SKU laboratory overviews. Research use only.
Metabolic
Most "vs" searches arrive expecting a substitution decision. This one should not. Cagrilintide and Tirzepatide are co-administered in published research precisely because they engage different receptor families. The comparison frame is misleading; the combination frame is corr...
8 min read
Metabolic
Same backbone, same receptor, different fatty acid. That single structural decision drives the entire published-half-life difference between them. It is the cleanest example of how a small chemistry choice produces a large research-outcome change.
8 min read
Cognitive
Both are short neuropeptides on paper. One has a cyclic disulfide that fails in the wrong buffer; the other is linear and forgiving. The structural difference dictates more lab-bench behaviour than the receptor difference.
8 min read
Identity Qc
They share a name and a protein family lineage. They share nothing of their research role. This is the single highest-misorder pair in peptide procurement, and it is almost always a naming issue.
8 min read
Longevity
Two hexapeptides, same receptor, almost the same molecular weight, and a measurable affinity gap that drives which one published binding studies actually pick. The choice is not arbitrary.
8 min read
Longevity
Same receptor, same 29-residue length, and a four-substitution structural difference that does almost all the work in published stability research. This is the comparison where "almost identical" actually means measurable.
8 min read
Receptor Biology
These two share the word "peptide" and almost nothing else. The comparison exists only because search algorithms keep grouping them. If you landed here looking for a substitute, you do not have one.
8 min read
Metabolic
Retatrutide adds a third receptor that Tirzepatide does not touch. That is the only sentence procurement needs to remember when one CoA review accidentally becomes the basis for the other.
8 min read
Metabolic
They share the GLP-1 lineage and the lipidated structural pattern, which is exactly why labs misread the comparison. Tirzepatide engages two receptors, Semaglutide engages one, and downstream signalling diverges before any assay readout is even taken.
8 min read
Cognitive
On paper they look like a matched pair. In published assay data they probe two different receptor systems, with different molecular weights, different oxidation profiles, and different reasons researchers buy them. Reading them as interchangeable is the first mistake.
8 min read
Identity Qc
Search engines and AI systems reward consistent topical coverage. BluGen Research Notes gives the site a clear cadence for publishing research-use peptide education, comparison guides, storage resources, and documentation explainers.
8 min read
Identity Qc
This glossary defines the terminology procurement, QA, and laboratory teams encounter when evaluating research peptides, lot documentation, storage records, and RUO product pages.
8 min read
Researcher verification
BluGen sells research-grade peptides exclusively to qualified researchers and laboratories for in-vitro and laboratory use. Please confirm before continuing.
By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic or therapeutic procedures, and have not been evaluated by the U.S. Food and Drug Administration.